{"nct_id":"NCT01332513","title":"An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2011-02-10","start_date_type":"ACTUAL","primary_completion_date":"2011-05-23","primary_completion_date_type":"ACTUAL","completion_date":"2011-05-23","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}